Video

Dr. Vokes on Different Settings in Head and Neck Cancer

Everett Vokes, MD, John E. Ultmann professor of Medicine and Radiation Oncology, physician-in-chief, University of Chicago Medical Center, chair, Department of Medicine, University of Chicago Medicine, discusses different settings of patients with head and neck cancer.

Everett Vokes, MD, John E. Ultmann professor of Medicine and Radiation Oncology, physician-in-chief, University of Chicago Medical Center, chair, Department of Medicine, University of Chicago Medicine, discusses different settings of patients with head and neck cancer.

There are traditionally 2 kinds of settings in head and neck cancer, explains Vokes. There are those with recurrent disease and those who were previously untreated with locoregionally advanced disease.

In both of these settings it is important to consider current treatments as well as new drugs that could benefit the patient, says Vokes. For example, in recurrent disease, if a patient is unable to receive salvage surgery or salvage radiation, physicians must look to systemic surgery.

Related Videos
Pooja Phull, MD
Jennifer Effie Amengual, MD
Michael R. Bishop, MD
Marwan G. Fakih, MD, discusses the FDA approval of sotorasib with panitumumab for the treatment of adult patients with KRAS G12C–mutated metastatic colorectal cancer.
C. Ola Landgren, MD, PhD
Aditya Bardia, MD, MPH, FASCO
FRCSI, FRCSEd, medical director, Thoracic Cancer Program, and associate executive director, AdventHealth Cancer Institute
Benjamin P. Levy, MD, clinical director, Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital; and associate professor, oncology, Johns Hopkins University School of Medicine
Russell Hales, MD, director, Thoracic Oncology Multidisciplinary Program, associate professor, clinical radiation oncology and molecular radiation sciences, and director, thoracic multidisciplinary clinic, John Hopkins University School of Medicine